GAVISCON Drug Patent Profile
✉ Email this page to a colleague
When do Gaviscon patents expire, and what generic alternatives are available?
Gaviscon is a drug marketed by Chattem Sanofi and is included in one NDA.
The generic ingredient in GAVISCON is aluminum hydroxide; magnesium trisilicate. There are one hundred and forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aluminum hydroxide; magnesium trisilicate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GAVISCON?
- What are the global sales for GAVISCON?
- What is Average Wholesale Price for GAVISCON?
Summary for GAVISCON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 7 |
| Clinical Trials: | 7 |
| Patent Applications: | 75 |
| Drug Prices: | Drug price information for GAVISCON |
| What excipients (inactive ingredients) are in GAVISCON? | GAVISCON excipients list |
| DailyMed Link: | GAVISCON at DailyMed |
Recent Clinical Trials for GAVISCON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Opera CRO, a TIGERMED Group Company | N/A |
| Nekkar Lab Srl | N/A |
| Medical University of South Carolina | Phase 2 |
Pharmacology for GAVISCON
US Patents and Regulatory Information for GAVISCON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chattem Sanofi | GAVISCON | aluminum hydroxide; magnesium trisilicate | TABLET, CHEWABLE;ORAL | 018685-001 | Dec 9, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chattem Sanofi | GAVISCON | aluminum hydroxide; magnesium trisilicate | TABLET, CHEWABLE;ORAL | 018685-002 | Dec 9, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
